We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Streamlines Critical Path Innovation Meetings Process
FDA Streamlines Critical Path Innovation Meetings Process
Researchers approaching the FDA with new drug development tools, such as potential biomarkers or innovative trial designs, now have a centralized place to bring their ideas for advice, thanks to a new streamlined system that replaces the old fragmented process.